ADTRALZA

LEO Pharma Inc🇨🇦 Health Canada

Approval Id: 9f1ea63af561382b
Drug Approval Canada Name: ADTRALZA
Product Name: ADTRALZA
Status: Marketed
Status Date: 2024-06-03
Original Market Date: 2024-06-03
Din: 02540193
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 84:06.28
Atc Original: D11AH07 TRALOKINUMAB
Atc Name: d 11 ah 07
Aig Number: 0163195001
Company Name: LEO Pharma Inc
Company Address: 6 Adelaide Street East, Suite 200, Toronto, Ontario, Canada, M5C 1H6
Company Detail Path: /organization/leo-pharma-inc

TRALOKINUMAB

300 MG / 2 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

9f1ea63af561382b

Type

Standard